MainReads
← Details
Real-world effectiveness and safety of zanubrutinib in Spanish patients with relapsed/refractory marginal zone lymphoma.
Martin-Moro F, Muntañola A, Gutiérrez X, Vázquez MS, Morais L, Amarika I, Diez-Feijóo R, Bastos-Oreiro M, Cruz B, Marco-Ayala J, Ramos S, Jiménez-Ubieto A, Galindo-Navarro P, Correa JG, Lavilla E, García-Herce C, Moreno M, Domingo-Doménech E, Domínguez N, Alonso A, Otero MJ, Comai A, Bengochea ML, Villegas Da Ros C, Gutiérrez NC, Lluch R, Fernández-Luis S, Soler JA, Cannata-Ortiz MJ, Medina Á, Martín-Consuegra S, Aceituno M, Villafuerte P, de Miguel D, Arguiñano JM, López J, Villalón L, Gulino H, López-Guillermo A, Salar A, Grupo Español de Linfomas/Trasplante de Médula ósea (GELTAMO)
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.